In FLO-1 xenografts, we found that SLC7A11 knockdown significantly enhanced the anti-tumour activity of APR-246 (Fig. 8b,c; Supplementary Fig. 8k), leading to synergistic reduction of intratumoral GSH levels and improved animal survival (Fig. 8d,e). The gene discussed is SLC7A11; the disease is neoplasm.